130 related articles for article (PubMed ID: 20941929)
1. [Neoadjuvant chemotherapy for advanced ovarian cancer].
Perlman S; Ben-Arie A
Harefuah; 2010 Jun; 149(6):377-81, 402. PubMed ID: 20941929
[TBL] [Abstract][Full Text] [Related]
2. Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer.
Vergote I; Amant F; Kristensen G; Ehlen T; Reed NS; Casado A
Eur J Cancer; 2011 Sep; 47 Suppl 3():S88-92. PubMed ID: 21944035
[TBL] [Abstract][Full Text] [Related]
3. The position of neoadjuvant chemotherapy within the treatment of ovarian cancer.
Van Gorp T; Amant F; Neven P; Berteloot P; Leunen K; Vergote I
Minerva Ginecol; 2006 Oct; 58(5):393-403. PubMed ID: 17006426
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy in ovarian cancer.
Park TW; Kuhn WC
Expert Rev Anticancer Ther; 2004 Aug; 4(4):639-47. PubMed ID: 15270667
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients.
Vergote I; De Wever I; Tjalma W; Van Gramberen M; Decloedt J; van Dam P
Gynecol Oncol; 1998 Dec; 71(3):431-6. PubMed ID: 9887245
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter study.
Ansquer Y; Leblanc E; Clough K; Morice P; Dauplat J; Mathevet P; Lhommé C; Scherer C; Tigaud JD; Benchaib M; Fourme E; Castaigne D; Querleu D; Dargent D
Cancer; 2001 Jun; 91(12):2329-34. PubMed ID: 11413522
[TBL] [Abstract][Full Text] [Related]
7. Residual cancer stem cells after interval cytoreductive surgery following neoadjuvant chemotherapy could result in poor treatment outcomes for ovarian cancer.
Lim MC; Song YJ; Seo SS; Yoo CW; Kang S; Park SY
Onkologie; 2010; 33(6):324-30. PubMed ID: 20523098
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer.
Vergote IB; De Wever I; Decloedt J; Tjalma W; Van Gramberen M; van Dam P
Semin Oncol; 2000 Jun; 27(3 Suppl 7):31-6. PubMed ID: 10952124
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survival.
Schwartz PE; Rutherford TJ; Chambers JT; Kohorn EI; Thiel RP
Gynecol Oncol; 1999 Jan; 72(1):93-9. PubMed ID: 9889037
[TBL] [Abstract][Full Text] [Related]
10. [Neo-adjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer treatment--a retrospective study].
Tkácová M; Vertaková-Krakovská B; Belohorská B; Miskovská V; Helpianska L; Ondrus D; Ondrusová M; Spánik S; Svec J
Klin Onkol; 2009; 22(6):273-7. PubMed ID: 20099745
[TBL] [Abstract][Full Text] [Related]
11. [Neoadjuvant chemotherapy in the treatment of ovarian cancer].
Lehoczky O
Orv Hetil; 2005 Sep; 146(38):1951-5. PubMed ID: 16238247
[TBL] [Abstract][Full Text] [Related]
12. The role of neoadjuvant chemotherapy in the treatment of advanced ovarian cancer.
Pectasides D; Farmakis D; Koumarianou A
Oncology; 2005; 68(1):64-70. PubMed ID: 15809522
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy for advanced ovarian cancer.
Schwartz PE; Chambers JT; Makuch R
Gynecol Oncol; 1994 Apr; 53(1):33-7. PubMed ID: 8175019
[TBL] [Abstract][Full Text] [Related]
14. Preliminary results of neoadjuvant chemotherapy with paclitaxel and cisplatin in patients with advanced epithelial ovarian cancer who are inadequate for optimum primary surgery.
Lee SJ; Kim BG; Lee JW; Park CS; Lee JH; Bae DS
J Obstet Gynaecol Res; 2006 Feb; 32(1):99-106. PubMed ID: 16445534
[TBL] [Abstract][Full Text] [Related]
15. [Advanced ovarian cancer: primary debulking (PDS) or neoadjuvant chemotherapy (NACT) - still a debate].
Segev Y; Gemer O; Auslender R; Lavie O
Harefuah; 2014 Sep; 153(9):527-31, 558. PubMed ID: 25417489
[TBL] [Abstract][Full Text] [Related]
16. The role of neoadjuvant chemotherapy in treating advanced epithelial ovarian cancer.
Weinberg LE; Rodriguez G; Hurteau JA
J Surg Oncol; 2010 Mar; 101(4):334-43. PubMed ID: 20187069
[TBL] [Abstract][Full Text] [Related]
17. The role of neoadjuvant chemotherapy and interval laparotomy in advanced ovarian cancer.
Huober J; Meyer A; Wagner U; Wallwiener D
J Cancer Res Clin Oncol; 2002 Mar; 128(3):153-60. PubMed ID: 11935302
[TBL] [Abstract][Full Text] [Related]
18. [Initial or interval debulking surgery for advanced stage ovarian cancer: state-of-the-art. How to select patients?].
Morice P; Leblanc E; Narducci F; Pomel C; Pautier P; Chevalier A; Lhommé C; Castaigne D
Gynecol Obstet Fertil; 2005; 33(1-2):55-63. PubMed ID: 15752668
[TBL] [Abstract][Full Text] [Related]
19. Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients.
Colombo PE; Mourregot A; Fabbro M; Gutowski M; Saint-Aubert B; Quenet F; Gourgou S; Rouanet P
Eur J Surg Oncol; 2009 Feb; 35(2):135-43. PubMed ID: 18289825
[TBL] [Abstract][Full Text] [Related]
20. [The role of surgery for advanced epithelial ovarian cancer].
Hatae M; Onishi Y; Nakamura T; Wada T
Gan To Kagaku Ryoho; 1998 Jan; 25(2):201-7. PubMed ID: 9474929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]